Related by context. Frequent words. (Click for all words.) 64 Plenaxis R 61 ZALBIN 61 orphan designation 61 Rotarix R 60 Ceftobiprole 60 Marketing Authorization 60 Paladin Labs 60 FDA Orphan Drug 59 Pennsaid R 59 Protalix BioTherapeutics 59 Clevudine 59 Marketing Authorization Application 59 Vitaros 58 Marketing Authorization Application MAA 58 Loramyc ® 58 silodosin 58 orphan medicinal product 58 Icatibant 58 Toctino ® 58 ATryn R 58 FIRAZYR 58 Toctino R 57 PREOS 57 Patent Covering 57 Phase III Clinical Trial 57 Orphan Medicinal Product 57 Meda AB 57 THELIN 57 Isotretinoin 57 FDA Accepts 57 Orphan Drug designation 57 ATryn ® 56 Nimotuzumab 56 Positive Opinion 56 Investigational Device Exemption 56 Inc Therapeutic Competitors 56 BioDelivery Sciences 56 Clinical Trial Application 56 Angiox 56 Mutual Recognition Procedure 56 Somaxon Pharmaceuticals 56 Panzem R 56 Pirfenidone 56 Combidex 55 Generic Version 55 Orphan Drug status 55 Uracyst 55 Receives Regulatory 55 Drug Application 55 Pivotal Phase III 55 supplemental Biologics License Application 55 Presents Positive 54 submitted Biologics License 54 BEMA Fentanyl 54 Apricus Bio 54 Patient Enrollment 54 Anika Therapeutics 54 Oscient Pharmaceuticals 54 DC Bead 54 Virulizin R 54 Omacor 54 Orphan Drug Status 54 Fibrillex TM 54 Biologics License Application BLA 54 Par Pharmaceuticals 54 GEM #S 54 GlaxoSmithKline plc GSK 54 Drug Candidate 54 Analgesics 54 Uracyst ® 54 DepoMed 54 liposomal formulation 54 CE Marked 53 Clinical Trial Results 53 SCHWARZ PHARMA 53 Orphan Drug 53 Commercialization Agreement 53 taliglucerase alfa 53 Rebetol 53 Pivotal Trial 53 NASDAQ CRXL 53 alvimopan 53 Nasdaq VRTX 53 TRISENOX 53 NEBIDO 53 VANTAS 53 RISPERDAL ® CONSTA ® 53 Urocidin 53 Janssen Pharmaceutica NV 53 Satraplatin 53 Medicinal Products EMEA 53 methylnaltrexone 53 Telavancin 53 PLIVA dd 52 Amrubicin 52 Phenoptin 52 Completes Enrollment 52 application sNDA 52 Zelrix 52 Ferumoxytol 52 Octreotide